The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30
- 1 December 1996
- journal article
- review article
- Published by Springer Nature in Quality of Life Research
- Vol. 5 (6), 555-567
- https://doi.org/10.1007/bf00439229
Abstract
While quality of life (QOL) assessment is becoming more common, interpreting the results remains problematic. This paper demonstrates an approach to developing clinically-based interpretations for QOL outcomes, using the QLQ-C30 as an example. The results from 14 published QLQ-C30 studies which group patients by performance status, weight loss, toxicity, extent or severity of disease are collated. Groups with lower clinical status generally have worse QOL. The largest differences are between performance status groups, and the smallest differences are between groups of patients with local disease and those with metastases. The physical and role scores have the largest ranges of means across patient groups, and show the largest differences between clinical groups, while the cognitive and emotional scores have the smallest ranges of means and differences. Sicker groups have larger score standard deviations than healthie groups. Relatively large and small means and differences, and corresponding effect sizes, are presented. Collectively, the results provide a sense of the relative sizes of means and of differences, and of the types of clinical groups which give rise to them, thereby providing clinically-based benchmarks by which to interpret QLQ-C30 results.Keywords
This publication has 31 references indexed in Scilit:
- A comparison of two Quality-of-Life Questionnaires for cancer clinical trials: The Functional Living Index-Cancer (FLIC) and the Quality of Life Questionnaire Core module (QLQ-C30)Journal of Clinical Epidemiology, 1996
- Sample sizes for studies using the short form 36 (SF-36)Journal of Epidemiology and Community Health, 1995
- Quality of life measurement in patients with oesophageal cancer.Gut, 1995
- Statistical Versus Quantitative Significance in the Socioeconomic Evaluation of MedicinesPharmacoEconomics, 1994
- Determining a minimal important change in a disease-specific quality of life questionnaireJournal of Clinical Epidemiology, 1994
- Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnosesQuality of Life Research, 1993
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Quality of Life During Chemotherapy for Small Cell Lung Cancer: II. A longitudinal study of the EORTC Core Quality of Life Questionnaire and comparison with the Sickness Impact ProfileActa Oncologica, 1992
- Psychometric Validation of the Eortc Core Quality of Life Questionnaire, 30-Item Version and A Diagnosis-Specific Module for Head and Neck Cancer PatientsActa Oncologica, 1992
- Measurement of health statusControlled Clinical Trials, 1989